FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/09/045580 [Registered on: 16/09/2022] Trial Registered Prospectively
Last Modified On: 04/06/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study
Modification(s)  
Other (Specify) [Comparing 4 types of fluid in septic shock]  
Study Design  Randomized, Parallel Group, Multiple Arm Trial 
Public Title of Study
Modification(s)  
Balanced salt solutions versus saline 
Scientific Title of Study   Comparison of Acetate-based, Lactate-based and Multiple Electrolyte Solution versus saline (MeSLAc trial) in pediatric septic shock – A multicenter randomized controlled trial  
Trial Acronym  MesLAC 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Jhuma Sankar 
Designation  Additional Professor  
Affiliation  AIIMS 
Address  Room 3055, Department of Pediatrics
AIIMS Ansari Nagar, New Delhi
South
DELHI
110029
India 
Phone  09818399864  
Fax    
Email  jhumaji@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Jhuma Sankar 
Designation  Additional Professor  
Affiliation  AIIMS 
Address  Room 3055, Department of Pediatrics
AIIMS Ansari Nagar, New Delhi
South
DELHI
110029
India 
Phone  09818399864  
Fax    
Email  jhumaji@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Jhuma Sankar 
Designation  Additional Professor  
Affiliation  AIIMS 
Address  Room 3055, Department of Pediatrics
AIIMS Ansari Nagar, New Delhi
South
DELHI
110029
India 
Phone  09818399864  
Fax    
Email  jhumaji@gmail.com  
 
Source of Monetary or Material Support  
All India Institute of Medical Sciences  
 
Primary Sponsor  
Name  All India Institute of Medical Sciences 
Address  Department of Pediatrics Academic Block AIIMS 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Jhuma sankar  AIIMS   Room 3055, Department of Pediatrics AIIMS Ansari Nagar, New Delhi
South
DELHI 
09818399864

jhumaji@gmail.com 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institute Ethics Commitee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: I958||Other hypotension,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Multiple Electrolyte solution or Plasmalyte-A  Multiple Electrolyte Solution will be given as boluses of 10-20 ml/kg each for 7 days 
Intervention  Ringers Acetate  Ringers acetate fluid will be used as bolus in volumes of 10-20 ml/kg each for 7 days 
Intervention  Ringers lactate  Ringers lactate fluid will be given as boluses of 10-20 ml/kg each for 7 days  
Comparator Agent  Saline   0.9% NaCl will be used as boluses of 10-20 ml/kg each for 7 days  
 
Inclusion Criteria  
Age From  2.00 Month(s)
Age To  17.00 Year(s)
Gender  Both 
Details  Children 2 month to ≤ 17 years with features of septic shock –defined as children who have a suspected infection and have at least two clinical signs of decreased perfusion with or without hypotension.  
 
ExclusionCriteria 
Details  1. Children receiving fluid boluses before enrollment
2. Children with cardiogenic shock
3. Known patient with chronic kidney disease with baseline deranged renal function (eGFR < 90 ml/1.73 m2/min)
4. Severe malnutrition
5. Children whose parents refuse to give an informed consent
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant, Investigator, Outcome Assessor and Date-entry Operator Blinded 
Primary Outcome
Modification(s)  
Outcome  TimePoints 
To examine if use of any one of these balanced crystalloids - Ringers lactate, Ringers acetate or Plasmalyte A is superior to Saline in terms of lower incidence of composite end point of MAKE30 measured at day 30 ( Major Adverse Kidney events include- new onset or progressive AKI, in-hospital mortality, new renal replacement therapy, or persistent renal dysfunction at 30 days ) after initial fluid resuscitation.  Till 30 days of fluid resuscitation 
 
Secondary Outcome
Modification(s)  
Outcome  TimePoints 
a) Incidence of hyperchloremia & metabolic acidosis at 6 & 24 hours
b) Requirement of fluid boluses in first 6 hours & total fluids in first 24 hours, 48 hours & 72 hours.
c) Proportion of patients achieving the pre-determined therapeutic end points at 6 hours after intervention. Time to achievement of therapeutic goals.
d)In-ICU mortality rates
 
Hyperchloremia assessed at 6, 24, 48, 72 hours & 7 days
Total fluids received as boluses in first 6 hours & total fluids in 24 hours, 48 hours & 72 hours.
Proportion of patients achieving therapeutic end points & time taken for resolution of shock.
Mortality during ICU stay  
 
Target Sample Size
Modification(s)  
Total Sample Size="408"
Sample Size from India="408" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   18/09/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   NA 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  

Septic shock is a serious and concerning cause of morbidity and mortality in children. Fluid resuscitation is an important step in the early management of septic shock in children. Crystalloid solutions are recommended for initial fluid resuscitation;  saline (0.9% sodium chloride) is commonly used, as it is inexpensive and readily available with an efficacy similar to colloids with respect to shock resolution and mortality. Balanced crystalloids (BC)  have a composition resembling plasma with a lower chloride concentration than saline. Some balanced crystalloids (e.g., multiple electrolytes solution (MES) also known as Plasma-Lyte A) have been reported to be associated with decreased risk of metabolic disturbances such as hyperchloremia and metabolic acidosis as compared to saline in children from diverse patient settings. In a recently published systematic review in children, the authors tried to compare the effect of balanced versus unbalanced fluid on change in bicarbonate or pH within 24 hours in critically ill children. In the meta-analysis of 3 RCTs, the authors observed higher change in serum bicarbonate levels and pH level in the first 24 hours with balanced crystalloids.  However, the 3 studies pooled for the primary outcomes included children with gastroenteritis and compared Ringers Lactate with Saline or Plasmalyte with Saline.  The authors highlighted the need for larger pediatric trials to answer the clinically relevant questions pertaining to choice of fluid in critically ill children.

In a previous study by our group of 708 children, we observed lower risk of new or progressive AKI in the first 7 days after fluid resuscitation with the use of MES as compared to saline in children with septic shock. With this study we gained experience in conducting multicentre RCT addressing fluid resuscitation in children. However, in this study we compared only one type of balanced crystalloid with saline i.e. MES. The cost of MES is twice that of saline while that of Ringers lactate is similar to that of saline. Not only the cost, there are important differences between the different types of crystalloids available in the market. There are no studies comparing Ringers Acetate and Lactate amongst each other or with MES on metabolic parameters or AKI in children. The limited data available comparing these solutions in adult patients have found Ringers’ Acetate to have the advantage of extrahepatic metabolism with less oxygen demand compared to Lactate which is heavily dependent on liver for its metabolism. Using solutions in large volumes and/or rapid speed as is used in resuscitation may cause added burden on the already compromised liver and worsen its functions.  Multiorgan dysfunction carries high mortality and morbidity in children with septic shock. Finally, most studies comparing balanced crystalloids have evaluated the acid-base status and electrolyte abnormalities resulting from their infusion and there is a dearth of information on the impact of using various balanced crystalloids on patient-important outcomes such as mortality, hospital length of stay, and receipt or duration of life support and therefore the need for this study.

The Pediatric Surviving Sepsis Campaign (SSC) recently issued a recommendation to use balanced crystalloids, rather than saline, for the initial resuscitation in septic shock. This suggestion, however, was based on evidence of limited quality, prompting the SSC committee to comment in their report that the ‘type of fluid’ to be used for resuscitation should be a research priority.  The findings of this study would help address this research priority and provide important data with regard to choice of fluid in children with septic shock between various types of crystalloids. We plan to enrol 408 children (102 per group) in the study to address this important research question. 

 
Close